助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   静脉溶栓 在 急救医学 分类中 的翻译结果: 查询用时:1.448秒
图标索引 在分类学科中查询
所有学科
急救医学
心血管系统疾病
神经病学
临床医学
呼吸系统疾病
内分泌腺及全身性疾病
外科学
更多类别查询

图标索引 历史查询
 

静脉溶栓     
相关语句
  intravenous thrombolysis
    Study on Treatment Time Window for Intravenous Thrombolysis of Acute Ischemic Stroke
    静脉溶栓治疗急性缺血性脑卒中治疗时间窗的研究
短句来源
    Observation on therapeutic efficacy of urokinase intravenous thrombolysis in treating 50 cases with acute cerebral infarction
    尿激酶静脉溶栓治疗急性脑梗死50例疗效观察
短句来源
    Clinical analysis of streptokinase for treatment of acute myocardial infarction with different intravenous thrombolysis methods
    链激酶不同给药方法静脉溶栓治疗急性心肌梗死的临床疗效
短句来源
    Effect of early intravenous thrombolysis by urokinase on 34 patients with acute myocardial infarction
    早期尿激酶静脉溶栓治疗急性心肌梗塞34例临床观察
短句来源
    Analysis of reduction in ST-segment elevation after intravenous thrombolysis with urokinase in patients with AMI
    急性心肌梗死尿激酶静脉溶栓后ST段回降分析
短句来源
更多       
  intravenous thrombolytic therapy
    Experience of Intravenous Thrombolytic Therapy for Acute Myocardial Infarction in 100 Cases
    急性心肌梗塞静脉溶栓100例临床分析和体会
短句来源
    Relative factors study on intravenous thrombolytic therapy in acute myocardiac infarction
    尿激酶静脉溶栓治疗急性心肌梗塞疗效相关因素对比研究
短句来源
    The study of plasma fibrinolytic activity and GMP-140 level in patients with acute cerebral infarction during intravenous thrombolytic therapy
    急性脑梗塞患者静脉溶栓治疗期间血浆纤溶活性和GMP-140变化的研究
短句来源
    A clinical study of 100 patients with acute myocardial infarction treated by intravenous thrombolytic therapy through coronary angiography
    冠状动脉造影评价静脉溶栓治疗急性心肌梗塞100例临床疗效
短句来源
    The influence of intravenous thrombolytic therapy on incidence of aneurysm in patients with acute myocardial infarction
    静脉溶栓治疗急性心肌梗死患者对其室壁瘤形成的影响
短句来源
更多       
  venous thrombolysis
    Discussion on the efficiency and security of venous thrombolysis for patients aged more than 65 years with acute myocardial infarction
    65岁以上急性心肌梗塞患者静脉溶栓治疗的有效性及其安全性探讨
短句来源
    A comparison of efficacy of carotid artery thrombolysis and venous thrombolysis with urokinase in acute cerebral infarction
    尿激酶颈动脉溶栓与静脉溶栓治疗急性脑梗死患者疗效比较
短句来源
    Clinical control study on the treatment of acute cerebral infarction by supperselected intraaterial thrombolysis and venous thrombolysis
    超选择性动脉溶栓与静脉溶栓治疗急性脑梗死的临床对照研究
短句来源
    Methods A random control study was made by supperselected intraaterial thrombolysis in 30 cases and venous thrombolysis in 32 cases respectively.
    方法 对急性脑梗死患者 ,随机进行超选择性动脉灌注尿激酶溶栓治疗 30例和单纯静脉溶栓治疗 32例对照研究。
短句来源
    Clinical study by venous thrombolysis with urokinase on the treatment of 24 cases of acute brain infarction
    尿激酶静脉溶栓治疗急性脑梗塞
短句来源
更多       
  intravenous thrombolytic
    Experience of Intravenous Thrombolytic Therapy for Acute Myocardial Infarction in 100 Cases
    急性心肌梗塞静脉溶栓100例临床分析和体会
短句来源
    Relative factors study on intravenous thrombolytic therapy in acute myocardiac infarction
    尿激酶静脉溶栓治疗急性心肌梗塞疗效相关因素对比研究
短句来源
    The study of plasma fibrinolytic activity and GMP-140 level in patients with acute cerebral infarction during intravenous thrombolytic therapy
    急性脑梗塞患者静脉溶栓治疗期间血浆纤溶活性和GMP-140变化的研究
短句来源
    A clinical study of 100 patients with acute myocardial infarction treated by intravenous thrombolytic therapy through coronary angiography
    冠状动脉造影评价静脉溶栓治疗急性心肌梗塞100例临床疗效
短句来源
    The influence of intravenous thrombolytic therapy on incidence of aneurysm in patients with acute myocardial infarction
    静脉溶栓治疗急性心肌梗死患者对其室壁瘤形成的影响
短句来源
更多       

 

查询“静脉溶栓”译词为其他词的双语例句

 

查询“静脉溶栓”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  intravenous thrombolysis
Intravenous thrombolysis has become a standard in treatment of acute myocardial infarction.
      
There have been some prospective randomized studies which compared primary angioplasty with intravenous thrombolysis in patients with an acute myocardial infarction (AMI).
      
Intravenous thrombolysis seemed to be effective in improving functional and neurological outcome in a clearly defined subgroup of patients meeting the inclusion criteria of the studies.
      
Since treating ineligible patients is associated with an unacceptable risk of intracranial bleeding complications and death, intravenous thrombolysis should only be performed at selected centres in selected patients.
      
Because the clinical response to intravenous thrombolysis is exquisitely time-dependent, patients should be treated as soon as possible.
      
更多          
  intravenous thrombolytic therapy
Since the advent of intravenous thrombolytic therapy with recombinant tissue plasminogen activator (tPA) for acute ischemic stroke, there has been a marked change in our management approach to patients with acute ischemie stroke.
      
The use of intravenous thrombolytic therapy for the treatment of patients with acute ischemic stroke is now approved in the United States, Canada, Germany, and the European Union.
      
Forearm compartment syndrome following intravenous thrombolytic therapy for acute ischemic stroke
      
All patients underwent intravenous thrombolytic therapy with either streptokinase (1.5 million units/90 min) or tissue plasminogen activator (80 mg/90 min).
      
All patients had received intravenous thrombolytic therapy at the beginning of the insult.
      
更多          
  venous thrombolysis
In recent years, direct retrograde venous thrombolysis has become increasingly available, and has produced such remarkable results that it is likely soon to become the primary treatment of choice for the nontraumatic or nontumoral occlusions.
      
Venous thrombolysis by tissue-type plasminogen activator in conjunction with the urokinase-fibrinogen covalent conjugate
      
Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis.
      
One patient underwent arterial thrombolysis followed by venous thrombolysis and thrombectomy for insufficient venous return.
      
UK is the most commonly studied agent in the setting of peripheral arterial and venous thrombolysis.
      
  intravenous thrombolytic
Since the advent of intravenous thrombolytic therapy with recombinant tissue plasminogen activator (tPA) for acute ischemic stroke, there has been a marked change in our management approach to patients with acute ischemie stroke.
      
The use of intravenous thrombolytic therapy for the treatment of patients with acute ischemic stroke is now approved in the United States, Canada, Germany, and the European Union.
      
Forearm compartment syndrome following intravenous thrombolytic therapy for acute ischemic stroke
      
Timely reperfusion with intravenous thrombolytic agents has been shown to reduce mortality in patients with acute myocardial infarction.
      
All patients underwent intravenous thrombolytic therapy with either streptokinase (1.5 million units/90 min) or tissue plasminogen activator (80 mg/90 min).
      
更多          
  其他


点击这里查询相关文摘
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关静脉溶栓的内容
在知识搜索中查有关静脉溶栓的内容
在数字搜索中查有关静脉溶栓的内容
在概念知识元中查有关静脉溶栓的内容
在学术趋势中查有关静脉溶栓的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社